Juergen Horn
Founder of Invetx
Greater Boston
Overview
Work Experience
Founder & CEO
2018 - Current
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Raised $85,750,000.00 from Eight Roads Ventures, Tekla Capital Management, F-Prime Capital, Novo Holdings, Anterra Capital, Google Ventures and Casdin Capital.
Senior Advisor & Venture Partner
2018
Seeking investment opportunities in Animal Health Biotechnology
Chief Product Development Officer
2015 - 2017
Biopharmaceuticals transforming veterinary medicine.
Sr Director Global Innovation Strategy
2015 - 2015
Innovation Strategy & Portfolio Management, Elanco is part of Eli Lilly & Company
Elanco develops, manufactures and markets products for companion and food animals.
Raised $252,860,000.00 from Ancora.
Head Global Pharmaceuticals Development
2008 - 2014
Leading the global Development organization to bring new innovative products to the animal health market.
Head International Project Management & Drug Efficacy
2007 - 2008
Excellence in project management and clinical development.
Head Lead Finding - Program Office
2005 - 2006
Scouting for biotechnology innovation, cross-organizational synergies and transfer of technologies.
Head of Global Technical Services
2003 - 2004
Leading a global team for Marketing & Sales support, product stewardship and pharmacovigilance
Global Marketing - Professional Services
2001 - 2003
Marketing & Sales Support
Education
MBA
2005 - 2007
MBA
2005 - 2007
PhD
1998 - 2001
Dr.med.vet.
1997 - 1998